Predicting treatment response and clinicopathological findings in lupus nephritis with urine epidermal growth factor, monocyte chemoattractant protein-1 or their ratios

Predicting treatment response and clinicopathological findings in lupus nephritis with urine epidermal growth factor, monocyte chemoattractant protein-1 or their ratios

Show other versions (1)

<h4>Introduction</h4> There is a need for sensitive and specific biomarkers to predict kidney damage and therapeutic response in lupus nephritis (LN). Monocyte chemoattractant protein-1 (MCP-1) and epidermal growth factor (EGF) are cytokines with divergent roles. EGF or EGF/MCP1 ratio ha...

Full description

Bibliographic Details
Main Authors: Pintip Ngamjanyaporn, Suchin Worawichawong, Prapaporn Pisitkun, Khantong Khiewngam, Surasak Kantachuvesiri, Arkom Nongnuch, Montira Assanatham, Nuankanya Sathirapongsasuti, Chagriya Kitiyakara
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8912200/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8912200/?tool=EBI

Similar Items